百花医药(600721.SH):不涉及创新药研发

智通财经
Aug 11
【百花医药(600721.SH):不涉及创新药研发】智通财经APP讯,百花医药(600721.SH)发布股票交易风险提示公告称,公司是以小分子化学仿制药研发为主的CRO企业,主营业务是为客户提供小分子化仿药为主的药物研发注册“一站式”全流程服务,主要研发项目多来自于客户委托加部分的公司自主立项,不涉及创新药研发。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10